Pamela Ranghetti

653 total citations
20 papers, 284 citations indexed

About

Pamela Ranghetti is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Pamela Ranghetti has authored 20 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 9 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Pamela Ranghetti's work include Chronic Lymphocytic Leukemia Research (17 papers), Immune Cell Function and Interaction (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Pamela Ranghetti is often cited by papers focused on Chronic Lymphocytic Leukemia Research (17 papers), Immune Cell Function and Interaction (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Pamela Ranghetti collaborates with scholars based in Italy, United States and Greece. Pamela Ranghetti's co-authors include Paolo Ghia, Lydia Scarfò, Federico Caligaris‐Cappio, Marta Muzio, Cristina Scielzo, Benedetta Apollonio, Maria Teresa Sabrina Bertilaccio, Elisa ten Hacken, Graham Packham and Freda K. Stevenson and has published in prestigious journals such as Blood, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Pamela Ranghetti

20 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pamela Ranghetti Italy	9	168	130	73	70	69	20	284
Zsolt Zoltán Fülöp Romania	9	142 0.8×	85 0.7×	103 1.4×	121 1.7×	87 1.3×	17	326
Valentina Griggio Italy	10	208 1.2×	193 1.5×	90 1.2×	75 1.1×	144 2.1×	18	362
Noelia Purroy Spain	10	123 0.7×	159 1.2×	136 1.9×	113 1.6×	88 1.3×	18	334
Federico Pozzo Italy	10	87 0.5×	187 1.4×	102 1.4×	110 1.6×	38 0.6×	21	247
Jenny Bulgarelli Italy	10	167 1.0×	178 1.4×	78 1.1×	153 2.2×	98 1.4×	20	389
Ewa Wąsik‐Szczepanek Poland	10	196 1.2×	279 2.1×	158 2.2×	79 1.1×	75 1.1×	44	396
Nicole Weit Germany	6	105 0.6×	110 0.8×	79 1.1×	72 1.0×	62 0.9×	7	203
Josef Karban Czechia	8	113 0.7×	140 1.1×	102 1.4×	133 1.9×	61 0.9×	31	300
Reina Improgo United States	4	51 0.3×	107 0.8×	91 1.2×	100 1.4×	44 0.6×	7	231
Sebastian W. Hofbauer Austria	9	83 0.5×	142 1.1×	65 0.9×	213 3.0×	99 1.4×	10	354

Countries citing papers authored by Pamela Ranghetti

Since Specialization

Citations

This map shows the geographic impact of Pamela Ranghetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Ranghetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Ranghetti more than expected).

Fields of papers citing papers by Pamela Ranghetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Ranghetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Ranghetti. The network helps show where Pamela Ranghetti may publish in the future.

Co-authorship network of co-authors of Pamela Ranghetti

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Ranghetti. A scholar is included among the top collaborators of Pamela Ranghetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Ranghetti. Pamela Ranghetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Bordini, Jessica, Michela Riba, Pamela Ranghetti, et al.. (2024). Disrupting pro-survival and inflammatory pathways with dimethyl fumarate sensitizes chronic lymphocytic leukemia to cell death. Cell Death and Disease. 15(3). 224–224. 8 indexed citations

2.

Riba, Michela, et al.. (2023). Dimethyl itaconate selectively targets inflammatory and metabolic pathways in chronic lymphocytic leukemia. European Journal of Immunology. 53(10). e2350418–e2350418. 6 indexed citations

3.

Bordini, Jessica, Chiara Lenzi, Pamela Ranghetti, et al.. (2023). P1489: HIGH DOSE IRON IMPAIRS MALIGNANT B-CELL VIABILITY AND IMPROVES IMMUNE ANTITUMOR FUNCTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA. HemaSphere. 7(S3). e6299789–e6299789. 1 indexed citations

4.

Capasso, Antonella, Elisabetta Albi, Francesca Martini, et al.. (2022). CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL. Clinical Lymphoma Myeloma & Leukemia. 22. S279–S280. 2 indexed citations

5.

Bordini, Jessica, et al.. (2022). P597: HIGH DOSE IRON IMPAIRS MALIGNANT B-CELL VIABILITY IN CHRONIC LYMPHOCYTIC LEUKEMIA. HemaSphere. 6. 496–497. 2 indexed citations

6.

Ranghetti, Pamela, et al.. (2020). Interleukin‐1 receptor‐associated kinase 4 inhibitor interrupts toll‐like receptor signalling and sensitizes chronic lymphocytic leukaemia cells to apoptosis. British Journal of Haematology. 189(3). 475–488. 10 indexed citations

7.

Voso, Maria Teresa, Tatjana Pandzic, Eleonora De Bellis, et al.. (2020). Clonal Hematopoiesis Is Associated with Increased Risk for Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia Patients Treated with Chemo(immuno)Therapy. Blood. 136(Supplement 1). 19–20. 4 indexed citations

8.

Scarfò, Lydia, Silvia Ferrari, Anna Maria Frustaci, et al.. (2018). Ofatumumab Is Active and Safe in Patients with Relapsed/Refractory Splenic Marginal Zone Lymphoma (SMZL): Results from the Interim Analysis of an Italian Multicenter Phase 2 Study (MORE trial). Blood. 132(Supplement 1). 4162–4162. 1 indexed citations

9.

Gorini, Francesca, Laura Azzimonti, Gloria Delfanti, et al.. (2017). Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis. Blood. 129(26). 3440–3451. 63 indexed citations

10.

Reverberi, Daniele, Lydia Scarfò, Pamela Ranghetti, et al.. (2017). Toll-like receptor 9 stimulation can induce IκBζ expression and IgM secretion in chronic lymphocytic leukemia cells. Haematologica. 102(11). 1901–1912. 10 indexed citations

11.

Rodríguez, Tania Véliz, Pamela Ranghetti, Lydia Scarfò, et al.. (2017). The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia. Leukemia & lymphoma. 58(10). 2419–2425. 9 indexed citations

12.

McMahon, Kaylin M., Cristina Scielzo, Nicholas L. Angeloni, et al.. (2017). Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia. Oncotarget. 8(7). 11219–11227. 22 indexed citations

13.

Scarfò, Lydia, Mattias Mattsson, Aliki Xochelli, et al.. (2016). Ex Vivo Lymph Node Native Microenvironment Assay Shows Novel Antiproliferative Activity For Idelalisib And Ibrutinib On Cll Cells. Haematologica. 101. 426–426. 1 indexed citations

14.

Bianco, Mimma, Anna Maria Gasparri, Luca Generoso, et al.. (2016). Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models. Oncotarget. 7(27). 41725–41736. 7 indexed citations

15.

Agathangelidis, Andreas, Daniele Reverberi, Stavroula Ntoufa, et al.. (2015). Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation. Haematologica. 100(11). 1460–1468. 22 indexed citations

16.

Agathangelidis, Andreas, Lydia Scarfò, Federica Barbaglio, et al.. (2015). Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line. PLoS ONE. 10(6). e0130195–e0130195. 10 indexed citations

17.

Apollonio, Benedetta, Maria Teresa Sabrina Bertilaccio, Umberto Restuccia, et al.. (2014). From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia. Journal of Visualized Experiments. e51942–e51942. 3 indexed citations

18.

Apollonio, Benedetta, Maria Teresa Sabrina Bertilaccio, Umberto Restuccia, et al.. (2014). From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia. Journal of Visualized Experiments. 2 indexed citations

19.

Apollonio, Benedetta, Cristina Scielzo, Maria Teresa Sabrina Bertilaccio, et al.. (2013). Targeting B-cell anergy in chronic lymphocytic leukemia. Blood. 121(19). 3879–3888. 64 indexed citations

20.

Apollonio, Benedetta, Lydia Scarfò, Pamela Ranghetti, et al.. (2012). In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors. Clinical Cancer Research. 19(2). 367–379. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact